Advicenne: Funding, Investors & Team (Sep 2026)
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. Advicenne have spent more than 10 years developing products for the treatment of rare renal diseases. At Advicenne, we are committed to developing and commercializing medicines that are suitable for both children and adults – groundbreaking treatments for rare diseases should be available to patients of all ages.
Advicenne has raised $18.1M across 3 funding rounds on record, the most recent an undisclosed round of $1.7M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Advicenne Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Advicenne Funding Rounds
Advicenne raised $11.2M in an undisclosed round announced in Jun 2021.
1.5 years later, an undisclosed round of $5.2M was announced in Dec 2022.
3.5 years later, an undisclosed round of $1.7M was announced in Jun 2026.
Advicenne Founders and Leadership Team
Contact details for the Advicenne team: 1 of 2 have an email address on file.
Start 14-day free trial →Advicenne Funding Compared to Other Biotechnology Startups
Advicenne's latest round of $1.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Advicenne in Biotechnology and Nîmes
Companies Similar to Advicenne
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Kahimmune Therapeutics is a cutting-edge biotech startup that is repurposing the cancer immunopeptidome to…
Advicenne Funding FAQs
What does Advicenne do?
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. Advicenne have spent more than 10 years developing products for the treatment of rare renal diseases. At Advicenne, we are committed to developing and commercializing medicines that are suitable for both children and adults – groundbreaking treatments for rare diseases should be available to patients of all ages.
How much funding has Advicenne raised?
Advicenne has raised $18.1M across 3 rounds on record. The most recent is an undisclosed round of $1.7M announced in Jun 2026.
When did Advicenne last raise funding?
Advicenne's most recent funding round on record is an undisclosed round of $1.7M, announced in Jun 2026.
Who is the CEO of Advicenne?
David Horn Solomon is listed as CEO at Advicenne.
Where is Advicenne headquartered?
Advicenne is based in Nîmes, Languedoc-Roussillon, France.
How many employees does Advicenne have?
Advicenne is in the 11-50 employee band.
How does Advicenne's funding compare to other Biotechnology startups?
Advicenne's latest round of $1.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Advicenne Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Advicenne is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.